As of the close on December 15, 2022, Clovis Oncology, Inc.'s stock has declined approximately 96.08% over the past 52 weeks. The 50-day moving average sits at 0.68, while the 200-day moving average is 1.27.
| 52-Week Price Change | -96.08% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 1.27 |